Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here .

Happy Friday! I hope you’re having a better day than the 531 patients in Maine and New Hampshire who mistakenly received letters confirming their death .

We’ve also got some juicy details regarding Thursday’s big GLP-1 announcement. Let’s get to it.

What to know about Trump’s weight loss drug deals

The Trump administration wants to make it easier for Americans to afford popular anti-obesity drugs made by Novo Nordisk and Eli Lilly, announcing Thursday a deal to offer more coverage for Medicare and Medicaid beneficiaries and lower prices across the board.

The most popular drugs, Wegovy and Zepbound, carry list prices of around $1,000 a month, and are available dire

See Full Page